Tiziana Hongler

Tiziana Hongler

Baker & McKenzie Zurich


Tiziana Hongler is a member of Baker McKenzie's Intellectual Property & Technology practice group and Baker McKenzie's Healthcare and Life Sciences industry group.

After graduating from the University of Basel she has joined Baker McKenzie Zurich as a trainee lawyer and subsequently gained additional practical experience working in-house at Novartis Pharma AG for a period of six months.

Upon being admitted to the bar in 2022, she rejoined the Firm as an associate.

Practice Focus

Tiziana advises international and domestic clients on healthcare and life sciences regulatory and contractual matters (including in particular requests related to pharmaceutical or medical device regulatory law) under Swiss law. In addition, Tiziana advises on all aspects of intellectual property law with a particular focus on life science related matters and transactions including collaboration agreements, licensing agreements, R&D agreements etc.

Professional Associations and Memberships

  • Zurich Bar Association


  • Switzerland (2022)


  • University of Basel (Master of Law) (2018)
  • Erasmus University Rotterdam (Summer School on Health Law and Ethics) (2016)
  • University of Basel (Bachelor of Law) (2016)


  • English
  • German

Co-presenter, "EU-MDR vs.CH-MepV - Overcoming the EU/CH 'market access rift' in the post-MRA era," 18th annual Baker McKenzie Healthcare and Life Science Legal and Compliance Forum, November 2022

Co-author, "Switzerland: Software as a Medical Device," InsightPlus December 2022

Co-author, "Switzerland: The new Human Genetic Testings Act and Correlating Ordinances," InsightPlus November 2022,

Co-author, "Switzerland: Revision of Narcotics Act - Switzerland Fully Legalizes Medical Cannabis," InsightPlus September 2022

Co-author, "Switzerland: Price Disclosures in Consumer Transactions," InsightPlus, June 2022